Molecular imaging of prostate cancer
Current Opinion in Urology, 06/08/2012
Fox JJ et al. – Multiple positron emission tomography (PET) tracers are currently available to aid in the detection and management of prostate cancer across the clinical spectrum of the disease. Prospective, rigorously controlled, clinical imaging trials are needed to establish the optimal role of PET in prostate cancer.